Stay updated on Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Sign up to get notified when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.

Latest updates to the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page
- Check4 days agoChange DetectedRevision banner updated from v3.6.0 to v3.6.2, reflecting a small backend/template update rather than changes to the study details displayed on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status now indicates the study is not enrolling, and the page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) while adjusting the Intervention/Treatment label and including a revision note.SummaryDifference0.9%

- Check25 days agoChange DetectedRevision label on the study record updated from v3.5.4 to v3.5.5. This represents a minor metadata update to the page's version history.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now displays revision v3.5.4 instead of v3.5.3, indicating a backend/system update. This change does not alter the study information or content presented to users.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision tag v3.5.3 was added to the page's metadata. The previous revision tag v3.5.2 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedPage revision updated to v3.5.2; the previous revision v3.5.0 has been removed.SummaryDifference0.1%

Stay in the know with updates to Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single Dose GHB16L2 Trivalent Influenza Vaccine Clinical Trial page.